
CAS: 330942-05-7
Molecular Formula: C23H22ClN5O3
Molecular weight:451.91
Appearance:white powder
Density: 1.3g/cm3
Product description :Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE). .Betrixaban has undergone human clinical trials for prevention of embolism after knee surgery,and prevention of stroke following atrial fibrillation, with promising results.



